Home / Resource Library / IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma

IRF8 is a transcriptional activator of CD37 expression in diffuse large B-cell lymphoma

dlbcl, diffuse large b cell, cd37, irf8 transcription, gene, dna, prognosis, biomarker